Under oxaliplatin treatment, NFS1 inhibits PANoptosis in a S293 phosphorylation-dependent manner, suggesting that iron-sulfur cluster regulation may be a novel regulatory strategy of PANoptosis in cancer. This evidence concerns the gene NFS1 and cancer.